Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial.

van Anrooij B, Oude Elberink JNG, Span LFR, de Monchy JGR, Rosati S, Mulder AB, Kluin-Nelemans JC.

J Allergy Clin Immunol. 2018 Sep;142(3):1006-1008.e7. doi: 10.1016/j.jaci.2018.06.003. Epub 2018 Jun 8. No abstract available.

PMID:
29890238
2.

Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma.

Nieuwenhuis MA, Siedlinski M, van den Berge M, Granell R, Li X, Niens M, van der Vlies P, Altmüller J, Nürnberg P, Kerkhof M, van Schayck OC, Riemersma RA, van der Molen T, de Monchy JG, Bossé Y, Sandford A, Bruijnzeel-Koomen CA, Gerth van Wijk R, Ten Hacken NH, Timens W, Boezen HM, Henderson J, Kabesch M, Vonk JM, Postma DS, Koppelman GH.

Allergy. 2016 Dec;71(12):1712-1720. doi: 10.1111/all.12990. Epub 2016 Aug 22.

3.

Ulcerative colitis patients with an inflammatory response upon mesalazine cannot be desensitized: a randomized study.

Buurman DJ, De Monchy JG, Schellekens RC, van der Waaij LA, Kleibeuker JH, Dijkstra G.

Scand J Gastroenterol. 2015 Apr;50(4):399-405. doi: 10.3109/00365521.2014.962608. Epub 2015 Jan 29.

PMID:
25633468
4.

Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.

Vos BJ, van der Veer E, van Voorst Vader PC, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, de Monchy JG, van Doormaal JJ, Oude Elberink JN.

J Allergy Clin Immunol. 2015 Mar;135(3):792-8. doi: 10.1016/j.jaci.2014.05.047. Epub 2014 Aug 13.

PMID:
25129675
5.

Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis.

van der Veer E, Arends S, van der Hoek S, Versluijs JB, de Monchy JGR, Oude Elberink JNG, van Doormaal JJ.

J Allergy Clin Immunol. 2014 Dec;134(6):1413-1421. doi: 10.1016/j.jaci.2014.05.003. Epub 2014 Jun 27.

PMID:
24985401
6.

Allergology in Europe, the blueprint.

de Monchy JG, Demoly P, Akdis CA, Cardona V, Papadopoulos NG, Schmid-Grendelmeier P, Gayraud J.

Allergy. 2013 Oct;68(10):1211-8. doi: 10.1111/all.12225. Epub 2013 Sep 21. Review.

PMID:
24053537
7.

Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.

van Anrooij B, van der Veer E, de Monchy JG, van der Heide S, Kluin-Nelemans JC, van Voorst Vader PC, van Doormaal JJ, Oude Elberink JN.

J Allergy Clin Immunol. 2013 Jul;132(1):125-30. doi: 10.1016/j.jaci.2012.12.1578. Epub 2013 Mar 14.

PMID:
23498593
8.

Prevalence of indolent systemic mastocytosis in a Dutch region.

van Doormaal JJ, Arends S, Brunekreeft KL, van der Wal VB, Sietsma J, van Voorst Vader PC, Oude Elberink JN, Kluin-Nelemans JC, van der Veer E, de Monchy JG.

J Allergy Clin Immunol. 2013 May;131(5):1429-31.e1. doi: 10.1016/j.jaci.2012.10.015. Epub 2012 Dec 6. No abstract available.

PMID:
23219169
9.

Increase in vesicular hand eczema after house dust mite inhalation provocation: a double-blind, placebo-controlled, cross-over study.

Schuttelaar ML, Coenraads PJ, Huizinga J, De Monchy JG, Vermeulen KM.

Contact Dermatitis. 2013 Feb;68(2):76-85. doi: 10.1111/j.1600-0536.2012.02172.x. Epub 2012 Oct 10.

PMID:
23046099
10.

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions.

Alvarez-Twose I, Matito A, Sánchez-Muñoz L, Morgado JM, Orfao A, Escribano L, van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG.

Allergy. 2012 Sep;67(9):1190-1. doi: 10.1111/j.1398-9995.2012.02850.x. No abstract available.

PMID:
22882359
11.

Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.

van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG.

Allergy. 2012 May;67(5):683-90. doi: 10.1111/j.1398-9995.2012.02809.x. Epub 2012 Mar 22.

PMID:
22435702
12.

SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial.

Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R.

J Allergy Clin Immunol. 2012 Mar;129(3):717-725.e5. doi: 10.1016/j.jaci.2011.12.973. Epub 2012 Jan 29.

13.

High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.

van der Veer E, van der Goot W, de Monchy JG, Kluin-Nelemans HC, van Doormaal JJ.

Allergy. 2012 Mar;67(3):431-8. doi: 10.1111/j.1398-9995.2011.02780.x. Epub 2012 Jan 9.

PMID:
22229787
14.

Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.

Hofstra JJ, Kleine Budde I, van Twuyver E, Choi G, Levi M, Leebeek FW, de Monchy JG, Ypma PF, Keizer RJ, Huitema AD, Strengers PF.

Clin Immunol. 2012 Mar;142(3):280-90. doi: 10.1016/j.clim.2011.11.005. Epub 2011 Nov 16.

PMID:
22197071
15.

[Desensitisation to circumvent hypersensitivity reactions; treatment with docetaxel still possible].

Luiting J, de Monchy JG, Hiltermann TJ, Oude Elberink JN.

Ned Tijdschr Geneeskd. 2011;155:A2980. Dutch.

PMID:
21527052
16.

Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results.

van den Berge M, Pauw RG, de Monchy JG, van Minnen CA, Postma DS, Kerstjens HA.

Chest. 2011 Jan;139(1):190-3. doi: 10.1378/chest.10-0128.

PMID:
21208879
17.

Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis.

Niedoszytko M, Oude Elberink JN, Bruinenberg M, Nedoszytko B, de Monchy JG, te Meerman GJ, Weersma RK, Mulder AB, Jassem E, van Doormaal JJ.

Allergy. 2011 Feb;66(2):229-37. doi: 10.1111/j.1398-9995.2010.02477.x. Epub 2010 Sep 7.

PMID:
21208217
18.

Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.

Niedoszytko M, Bruinenberg M, van Doormaal JJ, de Monchy JG, Nedoszytko B, Koppelman GH, Nawijn MC, Wijmenga C, Jassem E, Elberink JN.

Allergy. 2011 May;66(5):648-57. doi: 10.1111/j.1398-9995.2010.02521.x. Epub 2010 Dec 8.

PMID:
21143240
19.

Intravenous voriconazole after toxic oral administration.

Alffenaar JW, van Assen S, de Monchy JG, Uges DR, Kosterink JG, van der Werf TS.

Antimicrob Agents Chemother. 2010 Jun;54(6):2741-2. doi: 10.1128/AAC.01193-09. Epub 2010 Apr 12.

20.

Application of a prediction model for work-related sensitisation in bakery workers.

Meijer E, Suarthana E, Rooijackers J, Grobbee DE, Jacobs JH, Meijster T, de Monchy JG, van Otterloo E, van Rooy FG, Spithoven JJ, Zaat VA, Heederik DJ.

Eur Respir J. 2010 Oct;36(4):735-42. doi: 10.1183/09031936.00171609. Epub 2010 Feb 11.

21.

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JG, Rak S, Scadding GK, Andersen JS, Riis B, Dahl R.

J Allergy Clin Immunol. 2010 Jan;125(1):131-8.e1-7. doi: 10.1016/j.jaci.2009.10.035.

PMID:
20109743
22.

Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization.

Kardaun SH, de Waard MM, de Monchy JG.

Contact Dermatitis. 2009 Jul;61(1):50-1. doi: 10.1111/j.1600-0536.2009.01553.x. No abstract available.

PMID:
19659967
23.

Mastocytosis in children: a protocol for management.

Heide R, Beishuizen A, De Groot H, Den Hollander JC, Van Doormaal JJ, De Monchy JG, Pasmans SG, Van Gysel D, Oranje AP; Dutch National Mastocytosis Work Group.

Pediatr Dermatol. 2008 Jul-Aug;25(4):493-500. doi: 10.1111/j.1525-1470.2008.00738.x.

PMID:
18789103
24.

Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.

Donker ML, van Doormaal JJ, van Doormaal FF, Kluin PM, van der Veer E, de Monchy JG, Kema IP, Kluin-Nelemans HC.

Haematologica. 2008 Jan;93(1):120-3. doi: 10.3324/haematol.11558.

25.

Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years.

Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Riis B, Grønager PM, Durham SR.

J Allergy Clin Immunol. 2008 Feb;121(2):512-518.e2. Epub 2007 Dec 26.

26.

Effect of ciclesonide treatment on allergen-induced changes in T cell regulation in asthma.

Heijink IH, Kauffman HF, Vellenga E, Veltman-Starkenburg CA, Postma DS, de Monchy JG.

Int Arch Allergy Immunol. 2008;145(2):111-21. Epub 2007 Sep 10.

PMID:
17848804
27.

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR.

J Allergy Clin Immunol. 2006 Aug;118(2):434-40.

PMID:
16890769
28.
29.

Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma.

Gauvreau GM, Boulet LP, Postma DS, Kawayama T, Watson RM, Duong M, Deschesnes F, De Monchy JG, O'Byrne PM.

J Allergy Clin Immunol. 2005 Aug;116(2):285-91.

PMID:
16083781
30.

The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis.

Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, Oosting AJ, de Monchy JG, Bruijnzeel-Koomen CA, van Wijk RG.

Allergy. 2005 Jul;60(7):888-93.

PMID:
15932378
31.

Exposure to TARC alters beta2-adrenergic receptor signaling in human peripheral blood T lymphocytes.

Heijink IH, Vellenga E, Oostendorp J, de Monchy JG, Postma DS, Kauffman HF.

Am J Physiol Lung Cell Mol Physiol. 2005 Jul;289(1):L53-9. Epub 2005 Mar 4.

32.

Comparison of a generic and a rhinitis-specific quality-of-life (QOL) instrument in patients with house dust mite allergy: relationship between the SF-36 and Rhinitis QOL Questionnaire.

Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, Oosting AJ, de Monchy JG, Bruijnzeel-Koomen CA, Gerth van Wijk R.

Clin Exp Allergy. 2004 Nov;34(11):1673-7.

PMID:
15544589
33.

Differential effect of mattress covers on the level of Der p 1 and Der f 1 in dust.

Tempels-Pavlica Z, Oosting AJ, Terreehorst I, van Wijk RG, Bruijnzeel-Koomen CA, de Monchy JG, Aalberse RC.

Clin Exp Allergy. 2004 Sep;34(9):1444-7.

PMID:
15347379
34.

Altered beta2-adrenergic regulation of T cell activity after allergen challenge in asthma.

Heijink IH, van den Berge M, Vellenga E, de Monchy JG, Postma DS, Kauffman HF.

Clin Exp Allergy. 2004 Sep;34(9):1356-63.

PMID:
15347367
35.
36.

Occupational asthma due to IgE mediated allergy to the flower Molucella laevis (Bells of Ireland).

Miesen WM, van der Heide S, Kerstjens HA, Dubois AE, de Monchy JG.

Occup Environ Med. 2003 Sep;60(9):701-3.

37.

Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults.

Kerkhof M, Dubois AE, Postma DS, Schouten JP, de Monchy JG.

Allergy. 2003 Sep;58(9):905-11.

PMID:
12911420
38.
39.

Evaluation of impermeable covers for bedding in patients with allergic rhinitis.

Terreehorst I, Hak E, Oosting AJ, Tempels-Pavlica Z, de Monchy JG, Bruijnzeel-Koomen CA, Aalberse RC, Gerth van Wijk R.

N Engl J Med. 2003 Jul 17;349(3):237-46.

40.

Interaction between nitric oxide and subsets of human T lymphocytes with differences in glutathione metabolism.

Roozendaal R, Kauffman HF, Dijkhuis AJ, Ommen ET, Postma DS, de Monchy JG, Vellenga E.

Immunology. 2002 Nov;107(3):334-9.

41.
42.

The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust mites.

Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, Oosting AJ, de Monchy JG, Bruijnzeel-Koomen CA, Post MW, Gerth van Wijk R.

Allergy. 2002 Oct;57(10):919-25.

PMID:
12269938
43.

Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study.

Oosting AJ, de Bruin-Weller MS, Terreehorst I, Tempels-Pavlica Z, Aalberse RC, de Monchy JG, van Wijk RG, Bruijnzeel-Koomen CA.

J Allergy Clin Immunol. 2002 Sep;110(3):500-6.

PMID:
12209102
44.
45.

Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis.

Terreehorst I, Oosting AJ, Tempels-Pavlica Z, de Monchy JG, Bruijnzeel-Koomen CA, Hak E, van Wijk RG.

Clin Exp Allergy. 2002 Aug;32(8):1160-5.

PMID:
12190652
46.

Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom.

Oude Elberink JN, De Monchy JG, Van Der Heide S, Guyatt GH, Dubois AE.

J Allergy Clin Immunol. 2002 Jul;110(1):174-82.

PMID:
12110838
47.

The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study.

Rijssenbeek-Nouwens LH, Oosting AJ, De Monchy JG, Bregman I, Postma DS, De Bruin-Weller MS.

Clin Exp Allergy. 2002 Jan;32(1):117-25.

PMID:
12002728
48.

Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy.

Oude Elberink JN, de Monchy JG, Golden DB, Brouwer JL, Guyatt GH, Dubois AE.

J Allergy Clin Immunol. 2002 Jan;109(1):162-70.

PMID:
11799384
49.

Anaphylaxis on skin exposure to grass.

Miesen WM, de Monchy JG, Dubois AE.

Allergy. 2001 Aug;56(8):799. No abstract available.

PMID:
11488689
50.

[Loss of an eye due to hyper-IgE syndrome after a corneal transplant].

Elberink JN, Dubois AE, de Monchy JG.

Ned Tijdschr Geneeskd. 2001 May 26;145(21):1031-2. Dutch. No abstract available.

PMID:
11407280

Supplemental Content

Loading ...
Support Center